The Goldilocks Window of Personalized Chemotherapy: An Immune Perspective
Derek S. Park, Mark Robertson-Tessi, Philip Maini, Michael B Bonsall, Robert A Gatenby, Alexander RA Anderson
This study uses mathematical modeling to show that optimal chemotherapy scheduling must balance tumor reduction and immune preservation to maximize treatment efficacy.
bioRxiv · Dec 13, 2018 · PreprintCancer Biology